Mylan Can't Launch Doryx Generic Just Yet
A New Jersey federal judge on Wednesday blocked Mylan Pharmaceuticals Inc. from launching a generic version of Warner Chilcott PLC's anti-acne medication Doryx....To view the full article, register now.
Already a subscriber? Click here to view full article